SFM
LGND icon

Systematic Financial Management’s Ligand Pharmaceuticals LGND Stock Holding History

Systematic Financial Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,540
Closed -$297K – 525
2020
Q1 		$297K Sell
6,540
-2,677
-29% -$152K 0.02% 319
2019
Q4 		$600K Hold
9,217
– – 0.02% 357
2019
Q3 		$572K Sell
9,217
-4,248
-32% -$267K 0.03% 263
2019
Q2 		$959K Sell
13,465
-3,006
-18% -$221K 0.04% 307
2019
Q1 		$1.29M Buy
+16,471
New +$1.25M 0.04% 346

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Systematic Financial Management's LGND Position: Q2 2020 in Review

Systematic Financial Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2020, closing a stake of 6,540 shares — an estimated $297K sold.

Systematic Financial Management first reported a position in LGND in Q1 2019 and held it in 5 quarters. The position peaked at $1.29M in Q1 2019. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

  • Systematic Financial Management reported no remaining Ligand Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Systematic Financial Management sold 6,540 Ligand Pharmaceuticals shares in Q2 2020, an estimated $297K.
  • Systematic Financial Management first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Systematic Financial Management's Ligand Pharmaceuticals position peaked at $1.29M in Q1 2019.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on Systematic Financial Management's 13F filing for Q2 2020, filed 13 Aug 2020.